Results 41 to 50 of about 27,286 (175)

AS1411 aptamer-functionalized exosomes in the targeted delivery of doxorubicin in fighting colorectal cancer

open access: yesBiomedicine & Pharmacotherapy, 2022
Severe side effects of chemotherapy agents on vital organs are the major causes of cancer-related mortality, not merely cancer disease. Encapsulating chemotherapeutic molecules in nanocarriers is a justifiable solution in decreasing the risk of their side effects and boosting the efficiency of treatment. The present study has developed the doxorubicin (
Nashmin Fayazi, Hosseini   +5 more
openaire   +2 more sources

Formulations Based on Drug Loaded Aptamer-Conjugated Liposomes as a Viable Strategy for the Topical Treatment of Basal Cell Carcinoma—In Vitro Tests

open access: yesPharmaceutics, 2021
Topical liposomal drug formulations containing AS1411-aptamer conjugated liposomes were designed to deliver in a sustained way the 5-fluorouracil to the tumor site but also to increase the compliance of patients with basal cell carcinoma.
Anca N. Cadinoiu   +5 more
doaj   +1 more source

AS1411-functionalized delivery nanosystems for targeted cancer therapy

open access: yesExploration of Medicine, 2021
Nucleolin (NCL) is a multifunctional nucleolar phosphoprotein harboring critical roles in cells such as cell proliferation, survival, and growth. The dysregulation and overexpression of NCL are related to various pathologic and oncological indications ...
Pooria Safarzadeh Kozani   +2 more
doaj   +1 more source

Aptamer-Functionalized Ce4+-Ion-Modified C‑Dots: Peroxidase Mimicking Aptananozymes for the Oxidation of Dopamine and Cytotoxic Effects toward Cancer Cells

open access: yes, 2022
Aptamer-functionalized Ce4+-ion-modified C-dots act as catalytic hybrid systems, aptananozymes, catalyzing the H2O2 oxidation of dopamine. A series of aptananozymes functionalized with different configurations of the dopamine binding aptamer, DBA, are ...
Pu Zhang (51027)   +9 more
core   +1 more source

AS1411-Induced Lipidomic Alterations and Therapeutic Insights in U-87 Glioblastoma Cells. [PDF]

open access: yesBiomolecules
Glioblastoma (GBM) is a devastating brain tumor heavily reliant on metabolic reprogramming for survival. The DNA aptamer AS1411 specifically targets cell-surface nucleolin (NCL), a protein overexpressed in GBM; however, its precise metabolic consequences
Kılıçkaya O, Şahin S.
europepmc   +2 more sources

Aptamer AS1411-functionalized gold nanoparticle-melittin complex for targeting MCF-7 breast cancer cell line [PDF]

open access: yesNanomedicine Journal, 2022
Objective(s): Several studies reported the apoptotic and lytic activity of melittin (Mel) in different tumor cells. In this study, a novel nano-complex was developed composed of AS1411aptamers, melittin and gold nanoparticle for the treatment of breast ...
Payam Bayat   +6 more
doaj   +1 more source

Interaction study of Dox-incorporated AS1411 aptamer and nucleolin by molecular dynamics simulation

open access: yes, 2023
AS1411 aptamer is able to recognise the nucleolin overexpressed on cancer cell membranes and has shown promise as a carrier of doxorubicin (Dox) to the cells. This study aimed to study the interaction between nucleolin and aptamers, in either the absence
Yuthana Tantirungrotechai (1429801)   +4 more
core   +1 more source

Development and Evaluation of AT11-Guided Liposomes for Human Papillomavirus Cancer

open access: yesMedical Sciences Forum, 2022
Conventional anticancer therapies present low specificity, leading to several secondary effects. To improve these drawbacks, aptamers able to fold into G-quadruplex (G4) are being used to promote drug accumulation in cancer cells.
Jéssica Lopes-Nunes   +2 more
doaj   +1 more source

AS1411-aptamer suppresses hepatocellular carcinoma by up-regulating galectin-14.

open access: yes, 2016
(A) DNA microarray results (volume plot of expression level, hierarchical clustering analysis) (B) Induction of LGALS-14 by the AS1411-aptamer was confirmed by RT-PCR under normoxic (20% O2 and 5% CO2 at 37°C) and hypoxic conditions (1% O2, 5% CO2, and ...
Su Jong Yu (313985)   +11 more
core   +1 more source

Anti-tumor effects of modified AS1411-aptamers on SNU-761 cells.

open access: yes, 2016
(A) Significant cytotoxic effects on SNU-761 cells were noted with modified AS1411-aptamer treatment under both normoxic and hypoxic conditions. (B) Cell cycle analysis revealed that modified AS1411-aptamer significantly decreased the proportion of S ...
Su Jong Yu (313985)   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy